These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19777193)

  • 1. Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea.
    Hur H; Song KY; Park CH; Jeon HM
    Ann Surg Oncol; 2010 Jan; 17(1):54-64. PubMed ID: 19777193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer.
    Min BH; Kim ER; Kim KM; Park CK; Lee JH; Rhee PL; Kim JJ
    Endoscopy; 2015 Sep; 47(9):784-93. PubMed ID: 26111362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer.
    Marrelli D; Pinto E; De Stefano A; Farnetani M; Garosi L; Roviello F
    Am J Surg; 2001 Jan; 181(1):16-9. PubMed ID: 11248169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of extragastric recurrence and the role of abdominal computed tomography in surveillance after endoscopic resection of early gastric cancer: Korean experiences.
    Lee S; Choi KD; Hong SM; Park SH; Gong EJ; Na HK; Ahn JY; Jung KW; Lee JH; Kim DH; Song HJ; Lee GH; Jung HY; Kim JH
    Gastric Cancer; 2017 Sep; 20(5):843-852. PubMed ID: 28130712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy.
    Kim DH; Oh SJ; Oh CA; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    J Surg Oncol; 2011 Nov; 104(6):585-91. PubMed ID: 21695697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer.
    McCall JL; Black RB; Rich CA; Harvey JR; Baker RA; Watts JM; Toouli J
    Dis Colon Rectum; 1994 Sep; 37(9):875-81. PubMed ID: 8076486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer.
    Eom BW; Ryu KW; Lee JH; Choi IJ; Kook MC; Cho SJ; Lee JY; Kim CG; Park SR; Lee JS; Kim YW
    Ann Surg Oncol; 2011 Feb; 18(2):358-64. PubMed ID: 21042946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of asymptomatic recurrence improves survival of gastric cancer patients.
    Park JS; Choe EA; Park S; Nam CM; Hyung WJ; Noh SH; Lee S; Kim HS; Jung M; Chung HC; Rha SY
    Cancer Med; 2021 May; 10(10):3249-3260. PubMed ID: 33932104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of CEA expression by RT-PCR in peritoneal wash from patients with gastric cancer: result of a 5-year follow-up after curative resection.
    Chae HD; Kim IH
    Scand J Gastroenterol; 2016 Aug; 51(8):956-60. PubMed ID: 27162096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMR for early gastric cancer in Korea: a multicenter retrospective study.
    Kim JJ; Lee JH; Jung HY; Lee GH; Cho JY; Ryu CB; Chun HJ; Park JJ; Lee WS; Kim HS; Chung MG; Moon JS; Choi SR; Song GA; Jeong HY; Jee SR; Seol SY; Yoon YB
    Gastrointest Endosc; 2007 Oct; 66(4):693-700. PubMed ID: 17905010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
    Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
    Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer.
    Park JH; Ryu MH; Kim HJ; Ryoo BY; Yoo C; Park I; Park YS; Oh ST; Yook JH; Kim BS; Kang YK
    Gastric Cancer; 2016 Jan; 19(1):226-33. PubMed ID: 25614467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
    Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A
    Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of endoscopic submucosal dissection in gastric neoplastic lesions at a single institution in South Korea.
    Jang JS; Choi SR; Qureshi W; Kim MC; Kim SJ; Jeung JS; Han SY; Noh MH; Lee JH; Lee SW; Baek YH; Kim SH; Choi PJ
    Scand J Gastroenterol; 2009; 44(11):1315-22. PubMed ID: 19891582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
    Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
    Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of patients resected for gastric cancer.
    Lacueva FJ; Calpena R; Medrano J; Compañ AF; Andrada E; Moltó M; Ferrer R; Diego M
    J Surg Oncol; 1995 Nov; 60(3):174-9. PubMed ID: 7475067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
    Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
    World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
    Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
    Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.